Wilmer Stalin Sanango Reinoso
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wilmer Stalin Sanango Reinoso has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Carmen Maricela Sevilla Rodríguez
Departamento de Enfermería en Traumatología, Hospital Homero Castanier Crespo Azogues-Ecuador
2 shared publications Jorge Oswaldo Herrera Ordoñez
Unidad de Nefrología, Hospital de Especialidades José Carrasco Arteaga, IESS, Cuenca-Ecuador
2 shared publications- Santiago David Silva Tobar
Servicio de Nefrología, Hospital General Docente Ambato-Ecuador
2 shared publications - Washington Osorio
Servicio de nefrología, Hospital de Especialidades Fuerzas Armadas N1, Quito
2 shared publications - Adriana Pamela Cabrera Eugenio
Servicio de Nefrología, Hospital Pablo Arturo Suárez, Quito, Ecuador
1 shared publication - Aida Valladarez Vázquez
Hospital Vicente Corral Moscoso-Cuenca
1 shared publication
Latest Publications
- Open Access
- 5 September 2025
- Published by Sociedad Ecuatoriana de Nefrologia, Dialisis y Trasplantes in Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante
- Vol. 14 (1) , 39-49
Autodeterminación en salud, como factor psicológico que influye en la supervivencia observacional y en la percepción de síntomas en pacientes en programas de hemodiálisis
Introduction: Self-determination in Health (SDH), defined as a patient's inherent ability to make informed and active decisions about their health care, is a modifiable psychological factor that correlates with motivation, proactive behavior, and improved physical health outcomes. In the context of hemodialysis (HD) therapy, SDH promotes functional autonomy and active patient engagement, even in the face of vulnerability; by contrast, its absence is associated with decision delegation and deterioration in health. The study hypothesizes that patients in hemodialysis programs with higher SDH will have a lower perception of symptoms and a longer survival. Methods: This observational, case-control study was carried out in 14 hemodialysis units in Ecuador from May to June 2025. Patients aged 18 years or older who were enrolled in hemodialysis programs were included. Two groups were formed: one with patients without SDH and the other with patients with SDH. The variables studied included age, duration of hemodialysis treatment, self-determination in health, adherence to treatment, labor integration, physical dependence, acceptance of kidney disease, and scores on "The Dialysis Symptom Index." A 1:1 propensity score matching (PSM) was performed between the groups based on age, sex, and presence of type 2 diabetes mellitus. The means were compared using Student's t-test, while proportions were compared using Chi-squared tests. An observational survival analysis was also conducted, examining the length of stay in the hemodialysis unit up to the date of the survey. Results: 180 patients without SDH and 184 with SDH were analyzed. Age was similar in both groups (57.9 ± 13.7 years vs. 58.0 ± 11.8 years, P = 0.938). The proportion of men was similar in both groups (51.1% vs. 51.6%; P=0.921). The prevalence of type 2 diabetes mellitus was comparable between the groups (48.3% vs. 47.3%; P=0.841). The group without SDH had a higher rate of physical dependence (53.3%) compared to the group with SDH (25.5%) (P < 0.001). Adherence was greater in the group with SDH (51.6%) than in the group without SDH (36.7%; P < 0.001). Work activity was more common among the group with SDH (38.0%) compared to 12.2% among the group without SDH (12.2%; P < 0.001). The group with SDH showed lower symptom intensity (–25.82%) than the group without SDH (P<0.001). Increased survival was observed in the SDH group, with 29.5 months versus 36.08 months in the non-SDH group (χ2, Log-Rank 7.71, P<0.005). Conclusions: Patients with SDH exhibited longer survival, significantly higher treatment adherence, and less physical dependence. Additionally, self-determination was associated with a reduction in the severity of perceived symptoms, including pain and psychological symptoms such as worry and sadness, across 18 of the 34 assessed. These findings demonstrate that SDH is not just a psychological concept but also a therapeutic goal that impacts survival. Randomized intervention studies in SDH are necessary.
- 5 September 2025
- Published by Sociedad Ecuatoriana de Nefrologia, Dialisis y Trasplantes in Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante
- Vol. 14 (1) , 39-49
Open AccessAutodeterminación en salud, como factor psicológico que influye en la supervivencia observacional y en la percepción de síntomas en pacientes en programas de hemodiálisis
Introduction: Self-determination in Health (SDH), defined as a patient's inherent ability to make informed and active decisions about their health care, is a modifiable psychological factor that correlates with motivation, proactive behavior, and improved physical health outcomes. In the context of hemodialysis (HD) therapy, SDH promotes functional autonomy and active patient engagement, even in the face of vulnerability; by contrast, its absence is associated with decision delegation and deterioration in health. The study hypothesizes that patients in hemodialysis programs with higher SDH will have a lower perception of symptoms and a longer survival. Methods: This observational, case-control study was carried out in 14 hemodialysis units in Ecuador from May to June 2025. Patients aged 18 years or older who were enrolled in hemodialysis programs were included. Two groups were formed: one with patients without SDH and the other with patients with SDH. The variables studied included age, duration of hemodialysis treatment, self-determination in health, adherence to treatment, labor integration, physical dependence, acceptance of kidney disease, and scores on "The Dialysis Symptom Index." A 1:1 propensity score matching (PSM) was performed between the groups based on age, sex, and presence of type 2 diabetes mellitus. The means were compared using Student's t-test, while proportions were compared using Chi-squared tests. An observational survival analysis was also conducted, examining the length of stay in the hemodialysis unit up to the date of the survey. Results: 180 patients without SDH and 184 with SDH were analyzed. Age was similar in both groups (57.9 ± 13.7 years vs. 58.0 ± 11.8 years, P = 0.938). The proportion of men was similar in both groups (51.1% vs. 51.6%; P=0.921). The prevalence of type 2 diabetes mellitus was comparable between the groups (48.3% vs. 47.3%; P=0.841). The group without SDH had a higher rate of physical dependence (53.3%) compared to the group with SDH (25.5%) (P < 0.001). Adherence was greater in the group with SDH (51.6%) than in the group without SDH (36.7%; P < 0.001). Work activity was more common among the group with SDH (38.0%) compared to 12.2% among the group without SDH (12.2%; P < 0.001). The group with SDH showed lower symptom intensity (–25.82%) than the group without SDH (P<0.001). Increased survival was observed in the SDH group, with 29.5 months versus 36.08 months in the non-SDH group (χ2, Log-Rank 7.71, P<0.005). Conclusions: Patients with SDH exhibited longer survival, significantly higher treatment adherence, and less physical dependence. Additionally, self-determination was associated with a reduction in the severity of perceived symptoms, including pain and psychological symptoms such as worry and sadness, across 18 of the 34 assessed. These findings demonstrate that SDH is not just a psychological concept but also a therapeutic goal that impacts survival. Randomized intervention studies in SDH are necessary.
- Open Access
- 3 February 2024
- Published by Sociedad Ecuatoriana de Nefrologia, Dialisis y Trasplantes in Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante
- Vol. 12 (1) , 72-80
Nefropatía inducida por Ácido Aristolóquico.
Introduction: Aristolochic acids contain a carboxylic nitro phenanthrene group and can be found in medicinal herbs of the genus Aristolochia. Their nephrotoxicity has been confirmed in endemic geographic areas such as the Balkans of Europe and the Central American region. The clinical findings consist of tubulointerstitial nephropathy and generally go unnoticed until the advanced stages of chronic kidney disease. Objective of the review: The aim is to describe the main pathophysiological aspects and establish diagnostic and treatment criteria in patients with Aristolochic Acid Nephropathy. Essential points of the review: About 180 types of aristolochic acids (AAs) have been discovered, the most critical types AAΙ, AAΙΙ, AAΙΙΙa (AA C) and AAΙVa (AA D), which are differentiated according to the position of their hydroxyl radical (OH), hydrogen (H) and methoxyl (OCH3). AA-induced nephropathy occurs through at least five pathways that associate the depletion of intracellular glutathione, cellular damage due to induction of cell apoptosis, direct damage to the endoplasmic reticulum, and mitochondrial damage. This produces atrophic tubular injury and interstitial fibrosis; the metabolite has a bladder neoplastic effect. Conclusion: The incidence of aristolochic acid nephropathy is probably much higher than initially thought, and its existence should be considered in patients who present with chronic kidney disease with a tubulo-interstitial clinical pattern.
- 3 February 2024
- Published by Sociedad Ecuatoriana de Nefrologia, Dialisis y Trasplantes in Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante
- Vol. 12 (1) , 72-80
Open AccessNefropatía inducida por Ácido Aristolóquico.
Introduction: Aristolochic acids contain a carboxylic nitro phenanthrene group and can be found in medicinal herbs of the genus Aristolochia. Their nephrotoxicity has been confirmed in endemic geographic areas such as the Balkans of Europe and the Central American region. The clinical findings consist of tubulointerstitial nephropathy and generally go unnoticed until the advanced stages of chronic kidney disease. Objective of the review: The aim is to describe the main pathophysiological aspects and establish diagnostic and treatment criteria in patients with Aristolochic Acid Nephropathy. Essential points of the review: About 180 types of aristolochic acids (AAs) have been discovered, the most critical types AAΙ, AAΙΙ, AAΙΙΙa (AA C) and AAΙVa (AA D), which are differentiated according to the position of their hydroxyl radical (OH), hydrogen (H) and methoxyl (OCH3). AA-induced nephropathy occurs through at least five pathways that associate the depletion of intracellular glutathione, cellular damage due to induction of cell apoptosis, direct damage to the endoplasmic reticulum, and mitochondrial damage. This produces atrophic tubular injury and interstitial fibrosis; the metabolite has a bladder neoplastic effect. Conclusion: The incidence of aristolochic acid nephropathy is probably much higher than initially thought, and its existence should be considered in patients who present with chronic kidney disease with a tubulo-interstitial clinical pattern.
- Open Access
- 3 February 2024
- Published by Sociedad Ecuatoriana de Nefrologia, Dialisis y Trasplantes in Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante
- Vol. 12 (1) , 88-94
Parada cardiorrespiratoria intradiálisis y anafilaxia a membrana de dializador como probable etiología en un paciente con inicio de terapia sustitutiva renal por enfermedad renal crónica.
Introduction: During the dialysis session, hypersensitivity reactions to the dialyzer may occur. Clinically, these conditions can vary in severity, from pruritus, erythema, and facial edema to more severe conditions such as dyspnea, bronchospasm, tachypnea, cyanosis, shock, and cardiac arrest. We present an unusual case of repeated anaphylactic shock, possibly caused by the use of a dialyzer with a helixone membrane. Clinical case: 60-year-old hypertensive and type 2 diabetic woman who presented uremia with hypervolemia and underwent dialysis treatment in the hemodialysis program. During the sixth session, she witnessed cardiorespiratory arrest, with recovery of spontaneous circulation after advanced cardiopulmonary resuscitation. Management: Required management in intensive care with intravenous nitroprusside and intubation with mechanical ventilation. Evolution: Given a new treatment, he once again developed hemodynamic instability with hypotension at the beginning of treatment. She was transferred to the peritoneal dialysis program. Conclusion: An anaphylactic reaction to helixone associated with hypotension and anaphylactic shock is reported.
- 3 February 2024
- Published by Sociedad Ecuatoriana de Nefrologia, Dialisis y Trasplantes in Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante
- Vol. 12 (1) , 88-94
Open AccessParada cardiorrespiratoria intradiálisis y anafilaxia a membrana de dializador como probable etiología en un paciente con inicio de terapia sustitutiva renal por enfermedad renal crónica.
Introduction: During the dialysis session, hypersensitivity reactions to the dialyzer may occur. Clinically, these conditions can vary in severity, from pruritus, erythema, and facial edema to more severe conditions such as dyspnea, bronchospasm, tachypnea, cyanosis, shock, and cardiac arrest. We present an unusual case of repeated anaphylactic shock, possibly caused by the use of a dialyzer with a helixone membrane. Clinical case: 60-year-old hypertensive and type 2 diabetic woman who presented uremia with hypervolemia and underwent dialysis treatment in the hemodialysis program. During the sixth session, she witnessed cardiorespiratory arrest, with recovery of spontaneous circulation after advanced cardiopulmonary resuscitation. Management: Required management in intensive care with intravenous nitroprusside and intubation with mechanical ventilation. Evolution: Given a new treatment, he once again developed hemodynamic instability with hypotension at the beginning of treatment. She was transferred to the peritoneal dialysis program. Conclusion: An anaphylactic reaction to helixone associated with hypotension and anaphylactic shock is reported.
- Open Access
Tumores pardos múltiples en enfermedad renal crónica en paciente en hemodiálisis, a propósito de un caso
La enfermedad renal crónica grados avanzados con y sin terapias de reemplazo renal presenta hiperparatiroidismo secundario a trastornos del metabolismo óseo y mineral lo que aumento las alteraciones esqueléticas, anemia y riesgo cardiovascular. Los niveles séricos de calcio, fósforo, paratohormona, hemoglobina y las imágenes diagnósticas, ayudan al diagnóstico oportuno permitiendo un tratamiento óptimo para disminuir estas afecciones, sin embargo, existe el riesgo de desarrollar alteraciones óseas. Realizamos el análisis clínico de un paciente con tumores pardos consecuencia de hiperparatiroidismo secundario a enfermedad renal crónica.
Open AccessTumores pardos múltiples en enfermedad renal crónica en paciente en hemodiálisis, a propósito de un caso
La enfermedad renal crónica grados avanzados con y sin terapias de reemplazo renal presenta hiperparatiroidismo secundario a trastornos del metabolismo óseo y mineral lo que aumento las alteraciones esqueléticas, anemia y riesgo cardiovascular. Los niveles séricos de calcio, fósforo, paratohormona, hemoglobina y las imágenes diagnósticas, ayudan al diagnóstico oportuno permitiendo un tratamiento óptimo para disminuir estas afecciones, sin embargo, existe el riesgo de desarrollar alteraciones óseas. Realizamos el análisis clínico de un paciente con tumores pardos consecuencia de hiperparatiroidismo secundario a enfermedad renal crónica.
- Open Access
- 15 February 2023
- Published by Sociedad Ecuatoriana de Nefrologia, Dialisis y Trasplantes in Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante
- Vol. 11 (1) , 53-58
Análisis económico del control de la tensión arterial en pacientes que se realizan hemodiálisis, diálisis peritoneal cíclica ambulatoria y diálisis peritoneal automatizada
Introducción: El control de la tensión arterial (TA), es un objetivo fundamental, en los pacientes con enfermedad renal crónica estadio 5D, ya que la hipertensión y la hipotensión causan efectos adversos en la calidad de vida del paciente y predisponen al aumento del riesgo cardiovascular. El objetivo del presente estudio fue realizar un análisis económico de la prescripción de antihipertensivos en un grupo de pacientes en terapia sustitutuva de la función renal. Métodos: Se trata de un estudio transversal, realizado en el servicio de hemodiálisis del hospital “José Carrasco Arteaga”. Las variables fueron: tipo de diálisis, sexo, uso de antihipertensivos, tipo de antihipertensivos y costo. La muestra fue no probabilística. Resultados: Se analizan 174 pacientes, 73 (41.95%) en programa de hemodiálisis (HD), 80 (45.98%) en programa de diálisis peritoneal manual (DP) y 21 (12.07%) en diálisis peritoneal automatizada (DPA). Fueron 74% de hombres en HD, 39 casos (48.7%) en DP, 12 casos (57.14%) en DPA. El uso de antihipertensivos en HD fue del 84%, en DP fue del 86% y en DPA fue del 86%. El costo de antihipertensivos fue en HD 12.5 ± 8.7 USD, en DP 15.7 ± 22.4 y en DPCA 16.4 ± 18.6 USD P>0.05. Conclusión: el uso de antipertensivos en este grupo de estudio fue en mas del 84% en las diferentes modalidades de diálisis, sin diferencia estadítica en el análisis de costo.
- 15 February 2023
- Published by Sociedad Ecuatoriana de Nefrologia, Dialisis y Trasplantes in Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante
- Vol. 11 (1) , 53-58
Open AccessAnálisis económico del control de la tensión arterial en pacientes que se realizan hemodiálisis, diálisis peritoneal cíclica ambulatoria y diálisis peritoneal automatizada
Introducción: El control de la tensión arterial (TA), es un objetivo fundamental, en los pacientes con enfermedad renal crónica estadio 5D, ya que la hipertensión y la hipotensión causan efectos adversos en la calidad de vida del paciente y predisponen al aumento del riesgo cardiovascular. El objetivo del presente estudio fue realizar un análisis económico de la prescripción de antihipertensivos en un grupo de pacientes en terapia sustitutuva de la función renal. Métodos: Se trata de un estudio transversal, realizado en el servicio de hemodiálisis del hospital “José Carrasco Arteaga”. Las variables fueron: tipo de diálisis, sexo, uso de antihipertensivos, tipo de antihipertensivos y costo. La muestra fue no probabilística. Resultados: Se analizan 174 pacientes, 73 (41.95%) en programa de hemodiálisis (HD), 80 (45.98%) en programa de diálisis peritoneal manual (DP) y 21 (12.07%) en diálisis peritoneal automatizada (DPA). Fueron 74% de hombres en HD, 39 casos (48.7%) en DP, 12 casos (57.14%) en DPA. El uso de antihipertensivos en HD fue del 84%, en DP fue del 86% y en DPA fue del 86%. El costo de antihipertensivos fue en HD 12.5 ± 8.7 USD, en DP 15.7 ± 22.4 y en DPCA 16.4 ± 18.6 USD P>0.05. Conclusión: el uso de antipertensivos en este grupo de estudio fue en mas del 84% en las diferentes modalidades de diálisis, sin diferencia estadítica en el análisis de costo.